- Home
- CSR vs ABCL Comparison
CSR vs ABCL Comparison
Compare CSR & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSR
- ABCL
- Stock Information
- Founded
- CSR 1970
- ABCL 2012
- Country
- CSR United States
- ABCL Canada
- Employees
- CSR N/A
- ABCL N/A
- Industry
- CSR Real Estate Investment Trusts
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- CSR Real Estate
- ABCL Health Care
- Exchange
- CSR Nasdaq
- ABCL Nasdaq
- Market Cap
- CSR 953.1M
- ABCL 818.2M
- IPO Year
- CSR N/A
- ABCL 2020
- Fundamental
- Price
- CSR $59.97
- ABCL $2.53
- Analyst Decision
- CSR Buy
- ABCL Buy
- Analyst Count
- CSR 9
- ABCL 3
- Target Price
- CSR $72.22
- ABCL $7.50
- AVG Volume (30 Days)
- CSR 110.9K
- ABCL 4.2M
- Earning Date
- CSR 05-01-2025
- ABCL 05-08-2025
- Dividend Yield
- CSR 5.09%
- ABCL N/A
- EPS Growth
- CSR N/A
- ABCL N/A
- EPS
- CSR N/A
- ABCL N/A
- Revenue
- CSR $260,983,000.00
- ABCL $28,833,000.00
- Revenue This Year
- CSR $4.47
- ABCL N/A
- Revenue Next Year
- CSR $3.67
- ABCL $27.77
- P/E Ratio
- CSR N/A
- ABCL N/A
- Revenue Growth
- CSR N/A
- ABCL N/A
- 52 Week Low
- CSR $54.13
- ABCL $1.89
- 52 Week High
- CSR $76.16
- ABCL $4.34
- Technical
- Relative Strength Index (RSI)
- CSR 47.99
- ABCL 56.73
- Support Level
- CSR $56.65
- ABCL $2.31
- Resistance Level
- CSR $59.52
- ABCL $2.53
- Average True Range (ATR)
- CSR 2.92
- ABCL 0.18
- MACD
- CSR 0.20
- ABCL 0.06
- Stochastic Oscillator
- CSR 63.00
- ABCL 80.99
About CSR D/B/A Centerspace
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.